Pyng Medical Corp  

(Public, CVE:PYT)   Watch this stock  
Find more results for cve:pyt
0.0000 (0.00%)
Jan 16 - Close
CVE data delayed by 15 mins - Disclaimer
Currency in CAD
Range 0.06 - 0.06
52 week 0.03 - 0.10
Open 0.06
Vol / Avg. 10,724.00/23,093.00
Mkt cap 2.01M
P/E     -
Div/yield     -
EPS -0.04
Shares 28.48M
Beta -1.97
Inst. own     -

Key stats and ratios

Q3 (Sep '16) 2016
Net profit margin -4.80% -23.10%
Operating margin -1.11% -19.87%
EBITD margin - -13.08%
Return on average assets -4.77% -18.97%
Return on average equity -10.73% -37.94%
CDP Score - -


Suite 210 - 13480 Crestwood Place
+1-604-3037964 (Phone)
+1-604-3037987 (Fax)

Website links


Pyng Medical Corp. engineers and markets trauma and resuscitation products for frontline critical care personnel. The Company's product portfolio includes sternal intraosseous (sternal IO), pelvic stabilization and tourniquet devices. It develops medical devices for use by hospital staff, emergency medical services and military forces. The Company has developed and commercialized an intraosseous (IO) infusion system, FAST1 Intraosseous Infusion System, which provides vascular access to enable the administration of drugs, medications, fluids and blood that require emergency life-saving treatment. The Company's FASTResponder and FASTCombat devices provide fluids, medication and blood. Its T-POD Pelvic Stabilization devices provide treatment of pelvic fractures. Its MAT Tourniquet is applied by the wounded patient to stop life-threatening bleeding. The Complete Rapid Illuminated Cricothyrotomy (CRIC) is a medical product allowing for surgical airway intervention.

Officers and directors

Ronald Ray Blanck Independent Chairman of the Board
Mark F. Hodge President, Chief Executive Officer
George G. Dorin Chief Financial Officer, Corporate Secretary
Age: 62
Robert Di Silvio Director
Age: 61
Alan L. Moloff Director
Herbert A Toms III Director
Llewellyn J. Evans Jr. Independent Director